Prognostic alternative splicing signatures in esophageal cancer reveal SF3A3 as a key oncogenic splicing factor
{{output}}
Background: Esophageal cancer (ESCA) is a highly lethal malignancy with limited therapeutic options, largely due to late-stage diagnosis and molecular complexity. Dysregulated alternative splicing (AS) contributes to ESCA progres... ...
